This announcement is a separate document:
Titan Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director NATAN DAVID
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.